Cost of Revenue of Eiger BioPharmaceuticals, Inc. from 31 Dec 2020 to 31 Dec 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Eiger BioPharmaceuticals, Inc. annual and quarterly Cost of Revenue in USD history and change rate from 31 Dec 2020 to 31 Dec 2023.
  • Eiger BioPharmaceuticals, Inc. Cost of Revenue for the quarter ending 30 Sep 2023 was $115,000, a 91% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Cost of Revenue for 2023 was $24,000, a 99% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Cost of Revenue for 2022 was $1,837,000, a 147% increase from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Cost of Revenue for 2021 was $745,000.
Source SEC data
View on sec.gov
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)

Eiger BioPharmaceuticals, Inc. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $24,000 -$1,813,000 -99% 01 Jan 2023 31 Dec 2023 10-K 08 Apr 2024 2023 FY
2022 $1,837,000 +$1,092,000 +147% 01 Jan 2022 31 Dec 2022 10-K 08 Apr 2024 2023 FY
2021 $745,000 +$745,000 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023 2022 FY
2020 $0 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2023 2022 FY

Eiger BioPharmaceuticals, Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $115,000 -$1,116,000 -91% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q1 2023 $1,845,000 $118,000 +$8,000 +7.3% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $1,837,000 $345,000 +$241,000 +232% 01 Oct 2022 31 Dec 2022 10-K 08 Apr 2024 2023 FY
Q3 2022 $1,596,000 $1,231,000 +$913,000 +287% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $683,000 $151,000 -$119,000 -44% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $802,000 $110,000 +$57,000 +108% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $745,000 $104,000 01 Oct 2021 31 Dec 2021 10-K 17 Mar 2023 2022 FY
Q3 2021 $318,000 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $270,000 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $53,000 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.